Results 81 to 90 of about 78,579 (196)

Switching from batch to continuous granulation: A case study of metoprolol succinate ER tablets. [PDF]

Int J Pharm, 2022
Kotamarthy L, Feng X, Alayoubi A, Kumar Bolla P, Ramachandran R, Ashraf M, O'Connor T, Zidan A.   +7 more
europepmc   +1 more source

Development and validation of a method for the quantitative determination of metoprolol succinate in the air of the working area by high-performance liquid chromatography using mass spectra

Toxicological Review
Introduction. Metoprolol is a cardioselective blocker of β-adrenergic receptors. Drugs containing metoprolol have hypotensive, antianginal, antiarrhythmic effects. Moderately dangerous when taken orally, has a general toxic effect. Metoprolol is produced
A. Y. Savchenko, Ilya I. Kartamyshev, Pavel A. Zhiltcov, Natalya S. Dubovik   +3 more
semanticscholar   +1 more source

Metoprolol Succinate [PDF]

Reactions Weekly, 2021
openaire   +2 more sources

A randomized, cross-over trial of metoprolol succinate formulations to evaluate PK and PD end points for therapeutic equivalence. [PDF]

Clin Transl Sci, 2022
Mosley SA, Kim S, El Rouby N, Lingineni K, Esteban VV, Gong Y, Chen Y, Estores D, Feng K, Kim H, Kinjo M, Langaee T, Li Z, Schmidt SOF, Johnson JA, Frye RF, Fang LL, Zhao L, Binkley PF, Schmidt S, Cavallari LH.   +20 more
europepmc   +1 more source

Development, validation and greenness assessment of stability indicating RP-HPLC method for simultaneous quantification of dapagliflozin and metoprolol succinate in synthetic mixture

International Journal of Pharmaceutical Sciences and Drug Research
A novel, rapid, accurate, precise and simple stability indicating RP-HPLC method has been proposed and validated for the concurrent quantitation of Dapagliflozin and Metoprolol succinate in laboratory prepared mixture.
S. Rathod, Ayushi S. Shah, Nisarg C. Patel   +2 more
semanticscholar   +1 more source

EVALUATION OF EFFECTIVENESS OF MEDICATION THERAPY IN PATIENTS WITH ARTERIAL HYPERTENSION AND CHRONIC HEART FAILURE OF FUNCTIONAL CLASS I

Кубанский научный медицинский вестник, 2014
100 patients with CHF functional class (FC) I against the background of hypertensive disease of stage II with regular left ventricular (LV) ejection fraction (EF) (LVEF≥55%) took part in the research and were randomized into two groups. Group 1 consisted
K. S. Bondarenko
doaj  

Correction to: Five-year results of heart rate control with ivabradine or metoprolol succinate in patients after heart transplantation. [PDF]

Clin Res Cardiol, 2022
Rivinius R, Helmschrott M, Rahm AK, Darche FF, Thomas D, Bruckner T, Doesch AO, Katus HA, Ehlermann P.   +8 more
europepmc   +1 more source

Five-year results of heart rate control with ivabradine or metoprolol succinate in patients after heart transplantation. [PDF]

Clin Res Cardiol, 2022
Rivinius R, Helmschrott M, Rahm AK, Darche FF, Thomas D, Bruckner T, Doesch AO, Katus HA, Ehlermann P.   +8 more
europepmc   +1 more source

REGULATORY ADAPTIVE STATUS IN EVALUATION OF EFFECTIVENESS OF MEDICATION THERAPY IN PATIENTS WITH CHRONIC HEART FAILURE OF FUNCTIONAL CLASS III

Кубанский научный медицинский вестник, 2014
100 patients with CHF FC III against the background of ischemic heart disease (IHD) and/or stage III hypertensive disease (HD) who received complex therapy (quinapril, torasemide, spironolactone) took part in the research.
E. S. Rokotyanskaya
doaj  

Influence of therapy chronic heart failure of functional class III on regulatory adaptive status

Кубанский научный медицинский вестник, 2014
100 patients with CHF FC III against the background of ischemic heart disease (IHD) and/or stage III hypertensive disease (HD). All them administered of complex therapy (Quinapril, Torasemide, Spironolactone).
E. S. Rokotyanskaya
doaj